EnteroMedics (ETRM) ReCharge Trial Fails to Meet Predefined Efficacy Endpoints
Tweet Send to a Friend
EnteroMedics Inc. (NASDAQ: ETRM) announced results from its randomized ReCharge Pivotal Trial of VBLOC vagal blocking therapy for the treatment ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
